Skip to main content

Table 6 Comparison of laboratory data between survivals and deaths

From: Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

  Survival n = 39 non-survival n = 7 p-value
Total WBC    
   Leukocytosis(> 12,000/ul) 27 (69.2) 4 (57.1) 0.667
   Leukopenia(< 4,000/ul) 2 (5.1) 2 (28.6) 0.104
   Leukocytosis or leukopenia 29 (74.3) 6 (85.7) 0.667
Differential count    
   Band formation 35 (89.7) 7 (100) 1.000
   neutrophilia(> 7,500/ul) 29 (74.3) 4 (57.1) 0.385
   lymphocytopenia(< 1,000/ul) 16 (41.0) 5 (71.4) 0.220
Thrombocytopenia(< 150,000/ul) 7 (17.9) 5 (71.4) 0.009
Hemoglobin(g/dL) 12.6 (7.7, 15.8) 12.4 (10.0, 14.7) 0.866
C-reactive protein (mg/dL) 135 (50, 373) 97 (63, 227) 0.915
Glucose (mg/dL) 194.9 (90, 842) 152 (105, 264) 0.667
Sodium (meq/L) 134.6(124, 141) 134.4 (127, 140) 0.988
Creatinine > 1.6 mg/dL 5 (12.8) 4 (57.1)* 0.020
Hypoalbuminemia(< 3 g/dL) 22 (56.4) 7 (100)* 0.036
LRINEC score 5.1 (0, 12) 3.7 (0, 70 0.217
APACHE II 16.9 (2, 34) 21.3 (17, 27) 0.090
ICU stay (patient numbers) 23 (59.0) 7 (100) 0.078
post-OP ventilator (patient numbers) 21 (53.8) 7 (100)* 0.032
ICU stay (day) 2.5 (0, 16) 10.3 (7, 14)* < 0.001
Hospital stay(day) 36 (13, 87) 34.6 (14, 79) 0.635
  1. Data are presented as median (min, max) or frequency (%)
  2. APACHE, acute physiological, age, and chronic health evaluation
  3. Chronic liver dysfunction: liver cirrhosis, viral hepatitis(HBV, or HCV)
  4. *: The difference is significant (p < 0.05)